StoryFunding

YolTech completes $70M Series C funding round led by Loyal Valley Capital

YolTech Therapeutics

YolTech raised $70 million in Series C funding led by Loyal Valley Capital, valuing the company at a significantly higher level and accelerating expansion of clinical programs across multiple geographies.

  • Series C round raised $70 million, led by Loyal Valley Capital.
  • Funding accelerates YOLT-101 development in China and the United States.
  • Series C follows strong Phase I data and intellectual property validation.
Read the original · Press

More on YolTech Therapeutics

Primer